Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Merck Starts Commercial Production of First GMP-Compliant Cell Culture Media Manufacturing Line in China
Saturday, July 13, 2024Merck a global leader in science and technology has initiated the commercial production of its first GMP compliant manufacturing line for cell culture media in China
Sanyou Bio and BioGeometry Join Forces to Develop AI-Powered Antibody Drug Discovery Platform
Friday, July 12, 2024BioGeometry and Sanyou Bio have announced a strategic partnership to advance drug research and development BioGeometry known for its AIdriven protein design and Sanyou Bio a leader in innovative
ADM Korea Launches First Clinical Trial of Niclosamide-Based Anticancer Drug for Prostate Cancer Patients Resistant to Hormone Therapy
Friday, July 12, 2024ADM Korea a subsidiary of Hyundai Bioscience has announced plans to initiate clinical trials for their niclosamidebased oral metabolic anticancer drug targeting prostate cancer patients
Leqembi Receives Approval for Treating Alzheimer's Disease in Hong Kong
Thursday, July 11, 2024BioArctic AB and Eisai have announced that Leqembi a treatment for Alzheimers disease has been approved by the Department of Health in Hong Kong This approval marks its fifth global approval following the US Japan China and South Korea
Reviva Pharmaceuticals Receives European Patent for Brilaroxazine in Treating Pulmonary Hypertension
Thursday, July 11, 2024Reviva Pharmaceuticals Holdings Inc announced today that it has been granted European Patent EP by the European Patent Office for the use of brilaroxazine in treating pulmonary hypertension
Interius BioTherapeutics Secures HREC Approval and TGA Clearance for Phase 1 Trial of First-of-its-Kind In Vivo CAR Therapy for B Cell Cancers
Wednesday, July 10, 2024Interius BioTherapeutics a pioneering developer of in vivo cellspecific gene medicines has secured Human Research Ethics Committee approval and Clinical Trial Notification clearance
Amarin Partner EddingPharm Secures Approval for VASCEPA® (Icosapent Ethyl) in Mainland China to Reduce Cardiovascular Risk
Tuesday, July 09, 2024Amarin Corporation plc has announced that its partner in Mainland China EddingPharm has received regulatory approval from Chinas National Medical Products Administration
Eli Lilly's Acquisition of Morphic Therapeutic Aims to Enhance Treatments for Inflammatory Bowel Disease (IBD)
Tuesday, July 09, 2024Eli Lilly and Company has announced a definitive agreement to acquire Morphic Holding Inc a biopharmaceutical company specializing in oral integrin therapies for serious chronic diseases
PharmAbcine Gains Safety Approval for First Dose Group in Phase 1a/b Study of PMC-309 in Advanced or Metastatic Solid Tumors
Monday, July 08, 2024PharmAbcine Inc a clinicalstage biotech company focusing on innovative antibody therapeutics has announced that their VISTA targeting immuno oncology candidate PMC received safety approval
Hinova Pharmaceuticals Receives FDA Fast Track Designation for HP518 to Treat AR+ Triple-Negative Breast Cancer
Saturday, July 06, 2024Hinova Pharmaceuticals Inc a leading biopharmaceutical company focused on innovative cancer therapies announced today that the US Food and Drug Administration has granted Fast Track designation
